Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,420,670
- Total 13F shares
- 25,991,001
- Share change
- +3,729,494
- Total reported value
- $86,467,063
- Put/Call ratio
- 216%
- Price per share
- $3.33
- Number of holders
- 88
- Value change
- +$11,894,875
- Number of buys
- 44
- Number of sells
- 29
Report period
Q1 2021
Institutions
88
Top holders
10
ABUS full security history
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3%
|
5,978,355
|
$21,223,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
2,747,759
|
$9,755,000 | — | 31 Dec 2020 | |
| Think Investments LP |
13F
|
Company |
1%
|
2,000,000
|
$7,100,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.92%
|
1,821,107
|
$6,465,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
1,422,264
|
$5,049,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.69%
|
1,371,089
|
$4,868,000 | — | 31 Dec 2020 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.37%
|
725,000
|
$2,574,000 | — | 31 Dec 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.32%
|
637,292
|
$2,262,000 | — | 31 Dec 2020 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.25%
|
500,000
|
$1,775,000 | — | 31 Dec 2020 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.24%
|
465,317
|
$1,652,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
437,963
|
$1,555,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
404,363
|
$1,435,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
401,651
|
$1,425,000 | — | 31 Dec 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.19%
|
384,297
|
$1,364,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.19%
|
375,513
|
$1,622,000 | — | 31 Dec 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.17%
|
328,681
|
$1,167,000 | — | 31 Dec 2020 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.13%
|
250,000
|
$892,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
180,962
|
$642,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
122,700
|
$436,000 | — | 31 Dec 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.06%
|
117,478
|
$417,000 | — | 31 Dec 2020 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.06%
|
117,235
|
$416,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.06%
|
115,000
|
$408,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
114,203
|
$405,000 | — | 31 Dec 2020 | |
| LMR Partners LLP |
13F
|
Company |
0.05%
|
102,765
|
$365,000 | — | 31 Dec 2020 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.05%
|
99,925
|
$355,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
98,897
|
$351,000 | — | 31 Dec 2020 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
62,530
|
$222,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
59,250
|
$210,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
56,610
|
$201,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
56,314
|
$200,000 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
55,270
|
$196,000 | — | 31 Dec 2020 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
50,899
|
$181,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
47,280
|
$168,000 | — | 31 Dec 2020 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
45,100
|
$160,000 | — | 31 Dec 2020 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.02%
|
41,299
|
$154,000 | — | 31 Dec 2020 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.02%
|
40,280
|
$143,000 | — | 31 Dec 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
39,064
|
$139,000 | — | 31 Dec 2020 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.02%
|
35,825
|
$127,000 | — | 31 Dec 2020 | |
| One68 Global Capital, LLC |
13F
|
Company |
0.02%
|
31,880
|
$113,000 | — | 31 Dec 2020 | |
| Wealth Management Associates, Inc. |
13F
|
Company |
0.02%
|
31,570
|
$112,074 | — | 31 Dec 2020 | |
| MYDA Advisors LLC |
13F
|
Company |
0.02%
|
30,000
|
$107,000 | — | 31 Dec 2020 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
28,054
|
$99,000 | — | 31 Dec 2020 | |
| Creative Planning |
13F
|
Company |
0.01%
|
26,703
|
$95,000 | — | 31 Dec 2020 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.01%
|
26,221
|
$93,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
20,912
|
$75,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
19,151
|
$68,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
17,926
|
$64,000 | — | 31 Dec 2020 | |
| BENJAMIN F. EDWARDS & COMPANY, INC. |
13F
|
Company |
0.01%
|
16,400
|
$58,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
15,376
|
$55,000 | — | 31 Dec 2020 | |
| Platform Technology Partners |
13F
|
Company |
0.01%
|
15,000
|
$53,000 | — | 31 Dec 2020 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2021
As of 31 Mar 2021,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,991,001 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Hudson Bay Capital Management LP, ADVISOR GROUP HOLDINGS, INC., MORGAN STANLEY, Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, and CITADEL ADVISORS LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
72
Q1 2021 holders
88
Holder diff
16
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.